Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 1
1976 2
1977 1
1978 1
1981 4
1982 4
1983 1
1984 3
1985 2
1986 4
1987 6
1988 6
1989 10
1990 6
1991 5
1992 7
1993 4
1994 13
1995 5
1996 15
1997 9
1998 13
1999 10
2000 11
2001 20
2002 15
2003 16
2004 14
2005 18
2006 19
2007 12
2008 11
2009 13
2010 18
2011 21
2012 23
2013 14
2014 18
2015 22
2016 13
2017 15
2018 21
2019 22
2020 12
2021 20
2022 18
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Bassetti M, et al. Among authors: niki y. Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058795 Clinical Trial.
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Kohno S, Izumikawa K, Takazono T, Miyazaki T, Yoshida M, Kamei K, Ogawa K, Taniguchi S, Akashi K, Tateda K, Mukae H, Miyazaki Y, Okada F, Kanda Y, Kakeya H, Suzuki J, Kimura SI, Kishida M, Matsuda M, Niki Y. Kohno S, et al. Among authors: niki y. J Infect Chemother. 2023 Feb;29(2):163-170. doi: 10.1016/j.jiac.2022.10.010. Epub 2022 Oct 25. J Infect Chemother. 2023. PMID: 36307059 Free article. Clinical Trial.
[Cryptococcosis].
Yoshida K, Shoji H, Niki Y. Yoshida K, et al. Among authors: niki y. Nihon Rinsho. 2008 Dec;66(12):2350-5. Nihon Rinsho. 2008. PMID: 19069104 Review. Japanese.
S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis.
Niki Y, Adachi N, Fukata M, Fukata Y, Oku S, Makino-Okamura C, Takeuchi S, Wakamatsu K, Ito S, Declercq L, Yarosh DB, Mammone T, Nishigori C, Saito N, Ueyama T. Niki Y, et al. J Invest Dermatol. 2023 Feb;143(2):317-327.e6. doi: 10.1016/j.jid.2022.08.040. Epub 2022 Sep 5. J Invest Dermatol. 2023. PMID: 36063887 Free article.
Candidatus Mycoplasma haemohominis in Human, Japan.
Hattori N, Kuroda M, Katano H, Takuma T, Ito T, Arai N, Yanai R, Sekizuka T, Ishii S, Miura Y, Tokunaga T, Watanabe H, Nomura N, Eguchi J, Hasegawa H, Nakamaki T, Wakita T, Niki Y. Hattori N, et al. Among authors: niki y. Emerg Infect Dis. 2020 Jan;26(1):11-19. doi: 10.3201/eid2601.190983. Emerg Infect Dis. 2020. PMID: 31855136 Free PMC article.
Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.
Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, Kadota J, Kamei K, Kanda Y, Kiuchi T, Shibuya K, Takakura S, Takata T, Takesue Y, Teruya K, Tokimatsu I, Fukuda T, Maesaki S, Makimura K, Mikamo H, Mitsutake K, Miyazaki Y, Mori M, Yasuoka A, Yano K, Yamanaka N, Yoshida M. Kohno S, et al. Among authors: niki y. Med Mycol J. 2016;57(4):E117-E163. doi: 10.3314/mmj.16-00010. Med Mycol J. 2016. PMID: 27904053 Free article. Review. No abstract available.
[Quinolone].
Niki Y, Kobashi Y. Niki Y, et al. Nihon Rinsho. 2003 Feb;61 Suppl 2:750-5. Nihon Rinsho. 2003. PMID: 12722311 Review. Japanese. No abstract available.
Synoviolin is not a pathogenic factor for auto-inflammatory diseases.
Matsumoto T, Sato Y, Kobayashi T, Ito E, Soma T, Kimura A, Miyamoto K, Kobayashi S, Harato K, Matsumoto M, Nakamura M, Niki Y, Miyamoto T. Matsumoto T, et al. Among authors: niki y. Biochem Biophys Res Commun. 2021 Jun 18;558:183-188. doi: 10.1016/j.bbrc.2021.04.093. Epub 2021 Apr 28. Biochem Biophys Res Commun. 2021. PMID: 33932778
482 results